STRATEOS Trademark

Trademark Overview


On Friday, April 2, 2021, a trademark application was filed for STRATEOS with the United States Patent and Trademark Office. The USPTO has given the STRATEOS trademark a serial number of 90620233. The federal status of this trademark filing is REGISTERED as of Tuesday, October 25, 2022. This trademark is owned by Strateos, Inc.. The STRATEOS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service featuring software which provides access to remote and on- demand automated cloud labs accessible from a web browser that enable users around the world to easily access and control drug discovery, cell and gene therapy and synthetic biology workflows; software as a service featuring software for creating and managing workflows for designing laboratory experiments, for running laboratory experiments, generating data, for reviewing and analyzing laboratory and environmental data, and experiment results; providing scientific and laboratory support services to the pharmaceutical, biotechnology, healthcare, synthetic biology, agricultural science, and medical device industries, namely, research services, biopharmaceutical development, biologic assay development, preclinical research, clinical research, and pharmacovigilance; research and development in the field of biotechnology, healthcare delivery, synthetic biology, biopharmaceuticals, and pharmacovigilance, inclusi...
strateos

General Information


Serial Number90620233
Word MarkSTRATEOS
Filing DateFriday, April 2, 2021
Status700 - REGISTERED
Status DateTuesday, October 25, 2022
Registration Number6882488
Registration DateTuesday, October 25, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2022

Trademark Statements


Goods and ServicesSoftware as a service featuring software which provides access to remote and on- demand automated cloud labs accessible from a web browser that enable users around the world to easily access and control drug discovery, cell and gene therapy and synthetic biology workflows; software as a service featuring software for creating and managing workflows for designing laboratory experiments, for running laboratory experiments, generating data, for reviewing and analyzing laboratory and environmental data, and experiment results; providing scientific and laboratory support services to the pharmaceutical, biotechnology, healthcare, synthetic biology, agricultural science, and medical device industries, namely, research services, biopharmaceutical development, biologic assay development, preclinical research, clinical research, and pharmacovigilance; research and development in the field of biotechnology, healthcare delivery, synthetic biology, biopharmaceuticals, and pharmacovigilance, inclusive of preclinical research in the foregoing fields; software as a service featuring software for enabling organizations to control their own scientific instruments and facilities locally and worldwide, schedule workflows and manage their scientific data; software as a service featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; software as a service featuring software for research and development of chemicals, pharmaceuticals, biologics, and vaccines, and cell and gene therapies; software as a service featuring software for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments; conducting laboratory experiments on behalf of others; scientific testing services of chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; toxicology services, namely toxicological testing services of pharmaceuticals, chemicals, biologics, vaccines, and cell and gene therapies; research, design and scientific testing services in the field of biopharmaceuticals and synthetic biology; scientific development of custom assays for chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; technological consultancy in the field of information technology; technological consultancy in the field of life sciences, drug discovery, synthetic biology software engineering, hardware engineering and laboratory automation

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 10, 2021
Primary Code042
First Use Anywhere DateMonday, September 23, 2019
First Use In Commerce DateMonday, September 23, 2019

Trademark Owner History


Party NameStrateos, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Party NameStrateos, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Party NameStrateos, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events


Event DateEvent Description
Tuesday, October 25, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 25, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 9, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 15, 2021NON-FINAL ACTION E-MAILED
Wednesday, December 15, 2021NON-FINAL ACTION WRITTEN
Wednesday, November 17, 2021ASSIGNED TO EXAMINER
Saturday, July 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 6, 2021NEW APPLICATION ENTERED IN TRAM